CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 81.9% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Novavax NVAX

Novavax live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Oct 08, 17:18

Novavax (NVAX) Stock Could Be Above Fair Value As Plague Fears Fade

Novavax Inc
Webhose 2026 Oct 08, 08:21

Novavax (NASDAQ:NVAX) Sets New 12-Month High - Here's What Happened - Markets Daily

Novavax Inc
Webhose 2026 Oct 06, 13:56

Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna Nudges Higher, Pfizer Inches Higher

Novavax Inc
Webhose 2026 Oct 06, 08:20

Novavax (NASDAQ:NVAX) Reaches New 1-Year High - Time to Buy?

Novavax Inc
Webhose 2026 Oct 06, 03:34

NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'

Novavax Inc
Webhose 2026 Oct 05, 23:42

NVAX Stock Outruns Moderna As Vaxcyte's Shot Clears A Late-Stage Test

Novavax Inc
Webhose 2026 Oct 05, 19:40

Investors Purchase Large Volume of Novavax Call Options (NASDAQ:NVAX)

Novavax Inc
Webhose 2026 Oct 05, 19:02

Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up

Novavax Inc
Webhose 2026 Oct 05, 18:00

Novavax (NASDAQ:NVAX) Shares Up 10.5% - Here's Why

Novavax Inc
Webhose 2026 Oct 05, 11:01

Novavax (NASDAQ:NVAX) Stock Jumps 10.5% - Still a Buy? - Daily Political

Novavax Inc
Webhose 2026 Oct 05, 06:29

Novavax, Inc. (NASDAQ:NVAX) Stock Has Average Price Target of $14.00 According to Brokerages

Novavax Inc
Webhose 2026 Oct 03, 06:00

Novavax (NASDAQ:NVAX) Stock Crosses Above 200 Day Moving Average - What's Next?

Novavax Inc
Webhose 2026 Sep 18, 21:45

Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know

Novavax Inc
Webhose 2026 Sep 17, 16:26

Novavax (NVAX) Draws Focus On Policy Reform, Is It 34% Overvalued?

Novavax Inc
Webhose 2026 Sep 17, 09:28

Novavax, Inc. (NASDAQ:NVAX) Receives $14.00 Average Target Price from Brokerages - Markets Daily

Novavax Inc
Webhose 2026 Sep 17, 09:22

Novavax (NASDAQ:NVAX) Shares Up 8% - Time to Buy? - Daily Political

Novavax Inc
Webhose 2026 Sep 17, 07:44

Squarepoint Ops LLC Invests $1.26 Million in Novavax, Inc. $NVAX

Novavax Inc
Webhose 2026 Sep 16, 07:12

Novavax (NVAX) Could Be 32% Above Fair Value On Medicare Policy Fears

Novavax Inc
Webhose 2026 Sep 15, 01:42

Novavax (NASDAQ:NVAX) Upgraded at Wall Street Zen - Stock Observer

Novavax Inc
Webhose 2026 Sep 12, 23:48

Novavax (NASDAQ:NVAX) Upgraded to "Hold" at Wall Street Zen - Daily Political

Novavax Inc
Webhose 2026 Sep 12, 05:12

Novavax (NASDAQ:NVAX) Rating Increased to Hold at Wall Street Zen

Novavax Inc
Webhose 2026 Sep 11, 21:45

Novavax (NVAX) Laps the Stock Market: Here's Why

Novavax Inc
Webhose 2026 Sep 10, 18:02

Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot

Novavax Inc
Webhose 2026 Sep 10, 17:00

Novavax (NASDAQ:NVAX) Trading Down 6.5% - Here's Why

Novavax Inc
Webhose 2026 Sep 10, 06:29

Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of "Hold" by Brokerages

Novavax Inc
Webhose 2026 Sep 10, 05:02

Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor Conference

Novavax Inc

Novavax news

Latest news

Info

Spread

0.07

Spread (%)

0.6369 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Friday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1850691072

Shares Outstanding

164945726

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-1.58

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)

Latest Education Articles

Trustpilot